The AACR Annual Meeting is the focal point of the cancer research community, where scientists, clinicians, other health care professionals, survivors, patients, and advocates gather to share the latest advances in cancer science and medicine. From population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy; the AACR Annual Meeting highlights the work of the best minds in cancer research from institutions all over the world.

AACR Annual Meeting 2022 is scheduled for April 8-13, 2022, in New Orleans, LA. More details here: https://myaacr.aacr.org/LiveEventsList.

AACR 2022 News
How has the COVID-19 pandemic affected pediatric care?
May 3, 2022 -- What impact has the COVID-19 pandemic had on the care of pediatric cancer patients internationally? It depends on the country, according to Dr. Muhammed Elhadi of the University of Tripoli in Libya. Elhadi spoke with LabPulse.com at the recent American Association for Cancer Research meeting in New Orleans. Read More
New task force promotes pathology for cancer research
May 3, 2022 -- A new task force has been formed with the goal of promoting pathology’s role in cancer research, according to Anil Parwani, PhD, professor of pathology at Ohio State University. The task force hopes to increase the involvement of pathologists in cancer research, as well as generate interest in pathology among medical students. Read More
CoVac-1 vaccine shows promise for immunocompromised patients
May 2, 2022 -- At the recent American Association for Cancer Research meeting in New Orleans, LabPulse.com spoke with the University of Tübingen’s Dr. Juliane Walz, professor of peptide-based immunotherapies, and research associate Claudia Tandler about the promising results their CoVac-1 vaccine has shown in immunocompromised patients. Read More
AACR 2022 video: DCIS lesions may affect treatment
April 13, 2022 -- NEW ORLEANS -- In an interview with LabPulse.com, Tanjina Kader, PhD, of the Women's Cancer Research Program at the Sir Peter MacCallum Cancer Centre in Australia, shares an overview of her research on ductal carcinoma in situ (DCIS) at the American Association for Cancer Research (AACR) Annual Meeting. Read More
AACR 2022: Project GENIE spurs sharing of real-world data
April 12, 2022 -- NEW ORLEANS -- At this week's American Association for Cancer Research (AACR) 2022 annual meeting, LabPulse.com spoke with Shawn Sweeney, PhD, the director of the AACR Project GENIE Coordinating Center and project lead. Read More
AACR 2022: AACR taskforce tackles trust in science
April 11, 2022 -- NEW ORLEANS -- On day four of the American Association for Cancer Research (AACR) meeting, LabPulse.com spoke with Dr. Jesse Nodora, PhD, of the Moores Cancer Center at the University of California San Diego Health, a member of the new AACR taskforce devoted to the concept of trust in science. Read More
AACR 2022: Video preview of day 3
April 10, 2022 -- NEW ORLEANS - LabPulse.com Editor Leah Sherwood gives a preview of the events happening on day three of the American Association for Cancer Research (AACR) 2022 Annual Meeting. Read More
AACR 2022: What's the microbiome's role in cancer risk?
April 10, 2022 -- NEW ORLEANS - Does the microbiome provide clues to the precervical cancer risk of women? This is the question that Katherine Tossas, PhD, is investigating. She shared her thoughts on this topic and on reproductive justice in a video interview at the American Association for Cancer Research (AACR) annual meeting. Read More
AACR 2022 video: Pathomics for cancer research
April 9, 2022 -- NEW ORLEANS - What do the next-generation of pathology tools for cancer research look like, and how can pathologists contribute to those technologies to make an impact in their discipline? Dr. Beatrice Knudsen, PhD, of the Huntsman Cancer Institute at the University of Utah, explored these ideas at the American Association for Cancer Research (AACR) meeting in a video update from day two of the conference. Read More
AI spots patients at elevated risk for pancreatic cancer
April 8, 2022 -- An artificial intelligence (AI) algorithm can identify patients who have a 25-fold higher risk of developing pancreatic cancer within three to 36 months, according to a poster presentation at this week’s annual meeting of the American Association for Cancer Research in New Orleans. Read More
1
AACR 2022 Industry News
Guardant highlights data on multicancer test at AACR 2022
April 13, 2022 -- Guardant Health is highlighting research on its Guardant Shield multicancer assay presented at this week's annual meeting of the American Association for Cancer Research (AACR) in New Orleans. Read More
Natera highlights Signatera data at AACR
April 11, 2022 -- Natera is highlighting results from clinical studies on breast cancer that used its Signatera tumor-informed molecular residual disease test. The findings will be presented on April 12 at the American Association for Cancer Research (AACR) Annual Meeting in New Orleans. Read More
Accounting for genetic factors may improve PSA testing
April 11, 2022 -- Taking into account genetic factors that cause prostate-specific antigen (PSA) level changes could improve the detection of prostate cancer, according to research presented at the American Association for Cancer Research meeting in New Orleans. Read More
Stilla and Promega sign comarketing agreement
April 8, 2022 -- Stilla Technologies and Promega have established a comarketing agreement and will present data on a new digital polymerase chain reaction workflow model at the American Association for Cancer Research Annual Meeting on April 10 in New Orleans. Read More
C2i Genomics launches MRD test in Europe
April 6, 2022 -- C2i Genomics has launched its C2inform test for minimal residual disease (MRD) across Europe and announced the completion of clinical trials. The data will be presented at the 2022 American Association for Cancer Research meeting April 8-13. Read More
Genialis partners with OncXerna to improve targeted therapy
April 6, 2022 -- Genialis announced that its artificial intelligence software will be used to help classify patients for targeted cancer therapy using OncXerna's panel, an RNA-based pantumor biomarker. Read More
AACR announces 2022 cancer research award recipients
April 4, 2022 -- The American Association for Cancer Research (AACR) and partners Pelotonia and Victoria's Secret have announced five recipients of the Victoria's Secret Global Fund for Women's Cancers 2022 Meritorious Award. Read More
Biodesix NGS test highlighted in study
April 1, 2022 -- Biodesix is highlighting a study that used its GeneStrat next-generation sequencing (NGS) test for free nucleic acid analysis as a surrogate for tumor tissue biopsies. The results were published on March 17 in the journal Diagnostics (Basel). Read More
Personalis to present at AACR annual meeting 2022
March 24, 2022 -- Precision oncology firm Personalis will present new data at the scientific poster session at the American Association for Cancer Research (AACR) Annual Meeting 2022, held April 8-13. Read More
Guardant to highlight cancer screening studies at AACR
March 10, 2022 -- Guardant Health will highlight several studies of its portfolio of blood tests for cancer at the American Association for Cancer Research (AACR) annual meeting to be held April 8-13 in New Orleans. Read More